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Original Article
Objectives: Abdominal obesity increases mortality and morbidity from cardiovascular disease and there is a possibility that smoking 
effects obesity. However, previous studies concerning the effects of smoking on obesity are inconsistent. The objective of this study 
was to examine whether smoking is positively related to abdominal obesity in men with type 2 diabetes.
Methods: Subjects consisted of 2197 type 2 diabetic patients who visited Huh’s Diabetes Center from 2003 to 2009. Indices of abdom-
inal obesity were defined as visceral fat thickness (VFT) measured by ultrasonography and waist circumference (WC). Overall obesity 
was defined as body mass index (BMI). 
Results: Statistically significant differences in WC and VFT by smoking status were identified. However, there was no statistical differ-
ence in BMI according to smoking status. Means of WC and VFT were not significantly higher in heavy smokers and lower in mild smok-
ers. Compared to nonsmokers, the BMI confounder adjusted odds ratio and 95% confidence interval for VFT in ex-smokers and current-
smokers were 1.70 (1.21 to 2.39) and 1.86 (1.27 to 2.73), respectively. 
Conclusions: Smoking status was positively associated with abdominal obesity in type 2 diabetic patients. 
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tion, it has been reported that even with a body mass index 
(BMI) in the normal range, a significantly higher waist circum-
ference (WC) or waist to hip ratio (WHR) increases the possibil-
ity of complications and obesity-related diseases [2]. Despite 
having low BMI levels compared to Western populations, the 
Korean population is at risk for type 2 diabetes due to relative-
ly high central obesity and hypertension [3]. Recently, the rate 
of obesity has increased in Korea. According to the Korea Na-
tional Health and Nutrition Examination Survey, the overweight 
and obese Korean population over 20 years of age has preva-
lence rates of 36.7% for men and 27.4% for women [4].
Smoking prevention and smoking cessation play important 
roles in improving overall health, however, many teenagers 
and women start smoking mistakenly believing that it will help 
them lose weight. In fact, it has been reported that 60% of fe-
male smokers do so to maintain or lose weight [5]. The smok-
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INTRODUCTION
With the obesity epidemic on the rise, research on obesity 
has intensified. A previous study showed, that compared to 
overall obesity, abdominal obesity increases the risk of meta-
bolic diseases, such as cardiovascular disease (CVD), diabetes, 
hypertension, dyslipidemia, and insulin resistance [1]. In addi-
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ing prevalence of Korean men over 30 years of age decreased 
from 72.37% in 1992 to 52.43% in 2006 [6], but Korea has had 
a relatively high level of tobacco use among males worldwide. 
The association between smoking and obesity is as impor-
tant health issue because both smoking and increased body 
weight are independent risk factor for CVD. However, the ef-
fect on obesity according to smoking status or smoking amount 
is particularly controversial. According to data from the World 
Health Organization MONICA project (monitoring trends and 
determinants in cardiovascular disease), men and women 
who smoked generally had lower BMI than never smokers [7]. 
Several previous studies have been reported that among 
smokers a U-shaped relationship between the number of ciga-
rettes smoked and body wei ght [8,9]. In contrast, some studies 
claim that correlations between smoking and the distribution 
of fat are irrelevant [10]. The association of smoking and vis-
ceral fat among type 2 diabetic patients has not been exten-
sively researched. Such studies had relatively small sample siz-
es and inconsistent findings. Therefore, the objective of this 
study was to examine whether smoking is positively related to 
abdominal obesity as measured by visceral fat thickness (VFT) 
and WC in type 2 diabetic patients.
METHODS 
Study Subjects
We examined diabetes patients (n=9531) from January 
2003 to June 2009 at Huh’s Diabetes Center, a primary health 
care facility in Seoul, Korea. Our analysis only included men 
who had a smoking habit (n=3337) because of a low smoking 
pre valence among women. Patient exclusion criteria included 
1) diagnosis with type 1 diabetes (identified with a fasting 
C-pep tide level <0.5 ng/mL and with either a diagnosis of dia-
betes before the age of 30 years or a history of diabetic keto-
acidosis), 2) absence of VFT and WC measurements, 3) a histo-
ry of CVD, and 4) diagnosis with any type of cancer. A total of 
2197 patients with type 2 diabetes mellitus were eventually 
enrolled in the study. The Yonsei Medical University College of 
Medicine ethics committee approved the study protocol. 
Clinical and Biochemical Assessment
Patients were diagnosed with diabetes based on the Ameri-
can Diabetes Association criteria. For all participating patients, 
the study used data collected during the patient’s first visit. A 
single trained study staff member collected all the data, in-
cluding anthropometric indices. Participants were interviewed 
through a structured questionnaire in order to collect lifestyle 
data (such as smoking habits, alcohol consumption, and exer-
cise). They were asked to describe their smoking habit (never-
smoker, ex-smoker, or current smoker), alcohol consumption 
(nondrinker or drinker, regardless of the amount of alcohol), 
exercise routine (exercising or not exercising), as well as other 
demographic characteristics such as age, gender, and diabetes 
duration, and medication. The amount and duration of smok-
ing among current smokers was also recorded. Smoking amount 
was categorized as 1 to 10, 11 to 20, or ≥21. Weight and hei-
ght were measured for all subjects while they were wearing 
light clothing and not wearing shoes. Multiple measures of 
obesity indices were recorded and calculated, including BMI, 
WC, and VFT. BMI was calculated by dividing weight in kilo-
grams by the square of height in meters. WC was measured 
midway between the lower rib margin and iliac crest. VFT was 
measured by high-resolution ultrasonography [11-13] and de-
fined as the distance between the anterior wall of the aorta 
and the internal face of the rectoabdominal muscle perpen-
dicular to the aorta. Transverse scanning was performed using 
a 3.5 MHz probe to measure VFT at 1 cm above the umbilicus. 
Blood pressure was measured using a standard mercury sphyg-
momanometer after the subjects had been seated for at least 
10 minutes. Blood was collected after more than 10 hours of 
fasting, and fasting blood glucose, glycosylated hemoglobin, 
total cholesterol, high-density lipoprotein (HDL), triglycerides, 
and low-density lipoprotein were measured. 
Statistical Analysis
The results are presented as mean±SD or number (%).The 
partial correlation coefficient was used to describe the associa-
tion between VFT and other continuous variables of interest, 
after controlling for the effect of age. Differences in general 
characteristics between never-smoker, ex-smoker, and current 
smoker groups were compared using one-way ANOVA (for 
continuous variables) or the chi-square test (for categorical 
variables). The crude or adjusted mean VFT values were cate-
gorized according to smoking status and smoking amount. 
Analyses were adjusted for variables such as age, duration of 
diabetes, alcohol consumption, exercise, and BMI. We addi-
tionally adjusted for the use of any diabetes medication (med-
ication; no medication) and for hemoglobin A1c (HbA1c) lev-
els, in order to control for the effects of diabetes therapy or 
glycemic management.
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Moreover, we analyzed the subgroup of patients (n=453) 
with available smoking amount data. High VFT was defined as 
a VFT of ≥47.6 mm [13]. The nonsmoker group included nev-
er-smokers and ex-smokers. A multivariate logistic regression 
model was used to test the independent association between 
smoking and high VFT, adjusting for potential confounding 
variables such as age, diabetes duration, alcohol consumption, 
exercise, and BMI. All analyses were conducted using the SAS 
version 9.1 (SAS Inc., Cary, NC, USA). All statistical tests were 
two-sided, and statistical significance was accepted for 
p<0.05.
RESULTS
Our results showed that among the type 2 diabetic patients 
participating in the study, approximately 50% were ex-smok-
ers and 33.5% were current smokers. The mean age of partici-
pants was 55.5 years (age range, 28 to 87 years). The VFT mean 
values were 47.1, 49.2, and 49.8 mm for never-, ex-, and cur-
rent smokers, respectively (Table 1). Current smokers had high-
er HbA1c and lipid profile levels, compared to never-smokers 
and ex-smokers. Drugs used in the treatment of type 2 diabe-
tes include sulfonylurea, biguanide, acarbose, glitazone (TZDs), 
insulin, and statin. The percentage of type 2 diabetic patients 
who were on sulfonylurea, biguanide, acarbose, TZDs, insulin, 
and other hypoglycemic drugs were 51.7%, 36.7%, 12.2%, 9.7%, 
10.7%, and 0.4%, respectively. The prevalence of any diabetes 
medication was different among the 3 groups (data not shown).
VFT, which was determined using ultrasonography, was best 
correlated with WC (r=0.667, p<0.000), followed by BMI 
(r=0.627, p<0.000) (Table 2). The correlation between VFT 
and clinical laboratory values of HDL, cholesterol, triglycerides, 
blood pressure, and insulin was also significant.
Table 1. General characteristics of study population 
Never smoker (n=374) Ex-smoker (n=1087) Current smoker (n=736) p-value
Visceral fat thickness (mm) 47.1±18.4 49.2±18.5 49.8±17.7 0.06
Age (y) 56.8±11.4 57.7±9.6 51.5±9.7 <0.001
Duration of diabetes (y) 7.9±7.5 8.1±7.4 6.3±6.5 <0.001
BMI (kg/m2) 24.8±3.0 24.7±2.7 24.7±3.1 0.91
Waist circumference (cm) 86.4±7.7 86.7±7.8 86.6±8.0 0.85
Systolic blood pressure (mmHg) 135.5±17.8 135.0±17.3 130.3±17.0 <0.001
Diastolic blood pressure (mmHg) 87.8±11.6 87.5±11.0 87.0±12.0 0.47
Fasting plasma glucose (mg/dL) 156.2±57.2 153.8±54.7 168.5±60.7 <0.001
HbA1c (%) 8.2±1.9 8.1±1.8 8.7±2.0 <0.001
Total cholesterol (mg/dL) 185.6±36.3 188.8±39.4 196.4±39.7 <0.001
Triglyceride (mg/dL) 133.1±83.1 144.8±97.9 188.7±151.7 <0.001
HDL-cholesterol (mg/dL) 47.8±11.7 48.5±12.7 47.0±12.3 0.04
Insulin (pmol/L) 8.1±4.9 8.2±4.7 8.2±4.7 0.88
Alcohol drinking 
No 44.0 55.9 17.0 <0.001
Yes 56.0 44.1 83.0
Regular exercise
No 31.8 30.0 51.0 <0.001
Yes 68.2 70.0 49.0
Values are presented as mean±SD or percent.
BMI, body mass index; HbA1c, hemoglobin A1c; HDL, high density lipoprotein.
Table 2. Correlation between ultrasonography measured vis­
ceral fat thickness and the clinical values 
Crude Age adjusted
Correlation 
coefficient p-value
Correlation 
coefficient1 p-value
Waist circumference 0.668 <0.001 0.668 <0.001
Body mass index 0.628 <0.001 0.631 <0.001
Systolic blood pressure 0.181 <0.001 0.191 <0.001
Diastolic blood pressure 0.168 <0.001 0.168 <0.001
Triglyceride 0.243 <0.001 0.246 <0.001
High density lipoprotein -0.218 <0.001 -0.218 <0.001
Insulin 0.275 <0.001 0.275 <0.001
1Calculated using partial correlation analysis. 
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Table 3. The mean values of visceral fat thickness according to 
smoking status and smoking amount
Waist Visceral fat thickness
Crude Adjusted Crude Adjusted
Smoking status  
   Never smoker (n=736) 86.4±7.7 85.9±0.2 47.1±18.4 46.4±0.9
   Ex-smoker (n=1087) 86.7±7.8 86.6±0.2 49.2±18.5 49.0±0.5
   Current smoker (n=736) 86.6±8.0 86.8±0.2 49.8±17.7 49.4±0.7
   p-value 0.85 0.033 0.06 0.018
Smoking amount (d)1
   1-10 (n=121) 85.7±0.7 85.9±0.4 48.3±1.6 49.2±1.3
   11-20 (n=239) 86.3±0.5 86.6±0.3 48.7±1.1 48.7±0.9
   21+ (n=93) 87.6±0.8 87.1±0.4 51.9±1.8 51.4±1.5
   p-value 0.18 0.16 0.25 0.32
Adjusted for age, duration of diabetes, alcohol drinking, regular exercise, and 
body mass index.
1The amount of smoking was calculated among current smokers. 
The mean VFT values are shown according to smoking sta-
tus and amount in Table 3. Statistically significant differences 
in WC values were found between current smokers, ex-smok-
ers, and never-smokers after adjusting for age, duration of dia-
betes, alcohol consumption, regular exercise, and BMI. Among 
current smokers, the number of cigarettes smoked per day 
also positively correlated with the abdominal obesity indica-
tors WC and VFT, although the correlation was not statistically 
significant.
The association between smoking status and abdominal 
obesity, after adjusting for diabetes medication and HbA1c 
levels, was slightly attenuated but remained significant (Figure 
1). Current smokers had the highest WC and VFT values, fol-
lowed by ex-smokers, and then never-smokers. The BMI val-
ues, however, were not significantly different between current, 
never-, and ex-smokers. 
This study examined the independent risk of high VFT levels 
in relation to smoking status, by using multivariate logistic re-
gression analysis (Figure 2). The results showed that smoking 
significantly increased the risk of abdominal obesity, after ad-
justing for possible confounders such as BMI. We observed a 
linear increase in the odds ratio (OR) of abdominal obesity with 
increasing levels of both smoking status and amount. Patients 
who currently smoked more than 20 cigarettes per day had an 
adjusted OR of 1.93 (95% confidence interval, 1.16 to 3.21) com-
pared to never-smokers. 
DISCUSSION 
Our data indicates that type 2 diabetes patients who smoke 
have significantly higher central adiposity, according to VFT 
and WC values, than non-smokers. Heavy smokers particularly 
have higher central adiposity than light smokers. When further 
adjustment was made for diabetes medication and HbA1c lev-
els, this association between smoking status and abdominal 
obesity, although slightly attenuated, remained significant. 
Heavy smokers had higher abdominal obesity OR values than 
light smokers, even after adjusting for BMI. Among current 
smokers, heavy smokers showed significantly higher VFT val-
Figure 1. The means of body mass index (A), waist (B), and visceral fat thickness (C) according to smoking status. Body mass in­
dex was adjusted for age, alcohol drinking, regular exercise, duration of diabetes, medication of diabetes, and hemoglobin A1C. 
Waist and visceral fat thickness were adjusted for age, body mass index, alcohol drinking, regular exercise, duration of diabetes, 
medication of diabetes, and hemoglobin A1c.
Never smoker Ex-smoker Current smoker
25
24
23
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0
Body mass index A
p=0.31 87
86
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0
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0
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ues. For instance, participants who smoked more than 20 ciga-
rettes per day showed higher VFT values than those who smok-
ed less than 10 cigarettes per day. However, no dose-response 
relationship between the number of cigarettes smoked and 
abdominal obesity was observed.
Our study’s consistent results demonstrate that current smo-
kers have higher abdominal obesity than never- and ex-smok-
ers. Shimokata et al. [14] previously reported positive associa-
tion between smoking and abdominal obesity, regardless of 
whether BMI values were low. The WHR actually increased in 
patients who started smoking, despite their weight loss. How-
ever, according to data from the Scottish Health Survey, a de-
crease was observed in weight and BMI values of smokers com-
pared to non-smokers [15]. Additionally, a recent study con-
ducted in Turkey states that smoking inhibits visceral fat accu-
mulation in women [16]. The study found that current smokers 
showed 26% less fat mass and 30% less visceral adipose tissue 
than non-smokers, although the differences were statistically 
insignificant for the men’s data. Simon et al. [17] reported high-
er WHR for current smokers than subjects who quit smoking. 
Other studies claim that there is no significant association be-
tween smoking and fat distribution. Seidell et al. [10] state that 
smoking does not cause BMI increase, but that heavy smoking 
leads to higher WC. Moreover, one study claims that cigarette 
smoking is not related to a specific distribution pattern of body 
fat. Thus, studies report inconsistent conclusions regarding the 
relationship between obesity and smoking.
Some studies that claim an association between smoking 
and abdominal obesity have shown higher abdominal obesity 
levels in smokers compared to non-smokers; however, the me-
chanisms responsible for those results have not been proven 
conclusively. Previous studies have also shown an association 
between smoking and hormonal changes. Smokers of 2.4 mg 
Federal Trade Commission nicotine cigarettes have increased 
plasma beta-endorphin and cortisol levels, compared to non-
smokers [18]. Significantly, increased cortisol levels lead to in-
creased insulin resistance, which is associated with abdominal 
fat and diabetes [19]. Many epidemiological studies have de-
monstrated increased levels of testosterone, free testosterone, 
and androgen in men smokers [20-22]. In one such study, smo-
kers had higher mean plasma estradiol levels compared to 
non-smokers [23,24]. Exposure to androgens is linked to ab-
dominal fat in premenopausal women [25]. However, a nega-
tive correlation links testosterone and abdominal fat distribu-
tion in men [26]. Therefore, the relationship between smoking, 
body fat distribution, and sex hormones remains unclear and 
may be further complicated by confounding factors such as 
alcohol consumption and stress levels. 
Nicotine consumption was previously shown to temporarily 
enhance metabolism during resting as well as during light 
physical activity. However, there has been no evidence that 
nicotine enhances human body energy expenditure in the 
long term. Moreover, some studies have demonstrated that 
smokers and non-smokers have similar basal metabolic rates. 
On the other hand, it has also been reported that smokers tend 
to weigh less than non-smokers and that smokers gain weight 
after quitting. Several studies have demonstrated that body 
weight seems to be highest in ex-smokers, lowest in current 
smokers, and intermediate in never-smokers [27-29]. Never-
theless, these results are controversial (not all results follow 
this pattern), and the biological mechanism involved has not 
been established. Additionally, most studies have investigated 
the association between smoking and obesity in healthy sub-
jects. This association mechanism may be different in diabetes 
patients. Therefore, carefully designed follow-up studies of di-
abetic patients are required to consolidate the correlations do-
Figure 2. Odds ratio and 95% confidence interval for high visceral fat thickness according to smoking status (A) and smoking 
amount per day (B). 1Adjusted for age, duration of diabetes, alcohol drinking, regular exercise and body mass index.
3
2.5
2
1.5
1
Od
ds
 ra
tio
1
 Never smoker Ex-smoker Current smoker A
4
3
2
1
0
Od
ds
 ra
tio
1
Non smoker 1-10 11-20 21+ B
321
Smoking and Abdominal Obesity 
cumented in the present study. 
Nevertheless, this study has some limitations. First, we only 
used baseline measurements obtained during each individu-
al’s first visit, for characterization. We did not account for pos-
sible changes in smoking status or other lifestyle behaviors 
during follow-up; there is the possibility that diabetic patients’ 
WC, VFT, and glycemic control-related living habits had already 
changed by the time of the follow-up. Second, due to the cross-
sectional design, this study could not elucidate mechanisms 
or determine the direction of causality. Third, although we ad-
justed for several known potential confounders, we cannot 
completely rule out the possibility of residual confounding 
such as stress and secondhand smoke. Stress-dependent cor-
tisol values, in particular, have been strongly associated with 
abdominal obesity [30]. Finally, the contribution of fat mass 
distribution may vary among different populations. Accord-
ingly, our results may differ from those of studies using data 
obtained from women or other ethnic group participants. There-
fore, further investigation, using a longitudinal study design, is 
needed to determine whether smoking causes abdominal obe-
sity in general. 
This study also has several strengths. This study was perform-
ed using a relatively large cohort of type 2 diabetes performed 
in one institute. Additionally, both WC and VFT were measured 
using ultrasonography and were used as indices of abdominal 
obesity. Moreover, all data, including anthropometric indices, 
were obtained by a single trained study staff member. VFT is a 
simple noninvasive alternative to computed tomography and 
a reliable index for visceral fat measurement and identification 
of diabetic patients [13]. Furthermore, we assessed the associ-
ation of abdominal obesity with not only smoking status but 
also smoking amount. Previous studies have lacked such de-
tailed and accurate measurements of smoking amount. This 
study is important because it confirms a positive relationship 
between high smoking amount and abdominal obesity, where 
both are common risk factors in patients with type 2 diabetes.
In conclusion, our study found that smoking status was close-
ly related to abdominal obesity. Further research is needed to 
elucidate the association of smoking status and/or smoking 
patterns and abdominal obesity. The findings of this study 
should be cross-validated to different populations; hence, fur-
ther large-scale prospective studies are needed in type 2 dia-
betic patients. Re-evaluation of our conclusions should be con-
tinued since smoking may influence abdominal obesity, lead-
ing to other unfavorable health outcomes. 
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